Profound Medical (PROF) Competitors $5.68 +0.02 (+0.26%) As of 12:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROF vs. BBNX, AXGN, AVNS, KIDS, CBLL, BVS, SMLR, ZIMV, BFLY, and DCTHShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include Beta Bionics (BBNX), AxoGen (AXGN), Avanos Medical (AVNS), OrthoPediatrics (KIDS), CeriBell (CBLL), Bioventus (BVS), Semler Scientific (SMLR), ZimVie (ZIMV), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Profound Medical vs. Its Competitors Beta Bionics AxoGen Avanos Medical OrthoPediatrics CeriBell Bioventus Semler Scientific ZimVie Butterfly Network Delcath Systems Profound Medical (NASDAQ:PROF) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk. Do analysts prefer PROF or BBNX? Profound Medical presently has a consensus price target of $11.00, suggesting a potential upside of 91.67%. Beta Bionics has a consensus price target of $22.56, suggesting a potential upside of 49.37%. Given Profound Medical's stronger consensus rating and higher possible upside, analysts plainly believe Profound Medical is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75 Is PROF or BBNX more profitable? Beta Bionics has a net margin of 0.00% compared to Profound Medical's net margin of -269.35%. Beta Bionics' return on equity of 0.00% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-269.35% -70.41% -57.22% Beta Bionics N/A N/A N/A Does the media prefer PROF or BBNX? In the previous week, Beta Bionics had 6 more articles in the media than Profound Medical. MarketBeat recorded 7 mentions for Beta Bionics and 1 mentions for Profound Medical. Beta Bionics' average media sentiment score of 0.24 beat Profound Medical's score of 0.00 indicating that Beta Bionics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Beta Bionics 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings and valuation, PROF or BBNX? Profound Medical has higher earnings, but lower revenue than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$10.68M16.15-$27.82M-$1.22-4.70Beta Bionics$65.12M10.08-$54.76MN/AN/A Do insiders and institutionals hold more shares of PROF or BBNX? 47.9% of Profound Medical shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryBeta Bionics beats Profound Medical on 8 of the 14 factors compared between the two stocks. Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$172.46M$2.42B$5.44B$9.65BDividend YieldN/A1.78%3.99%4.14%P/E Ratio-4.7019.8930.0425.06Price / Sales16.15423.57373.4277.08Price / CashN/A165.0335.9458.58Price / Book2.864.158.125.67Net Income-$27.82M$31.61M$3.25B$265.39M7 Day Performance4.35%0.57%0.96%2.54%1 Month Performance-4.19%2.67%2.69%1.89%1 Year Performance-40.34%4.41%28.08%24.09% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical1.8151 of 5 stars$5.69+0.3%$11.00+93.5%-40.9%$170.83M$10.68M-4.66150News CoverageUpcoming EarningsBBNXBeta Bionics2.4926 of 5 stars$13.99-5.7%$23.44+67.6%N/A$643.41M$65.12M0.00294AXGNAxoGen2.1176 of 5 stars$12.99-2.8%$24.50+88.6%+77.7%$608.92M$187.34M-86.59450Analyst RevisionGap UpHigh Trading VolumeAVNSAvanos Medical1.6553 of 5 stars$12.02+0.1%N/A-52.4%$555.39M$687.80M-1.442,227Earnings ReportKIDSOrthoPediatrics3.9061 of 5 stars$22.39-1.6%$35.83+60.0%-29.2%$552.52M$204.73M-12.79200Earnings ReportAnalyst ForecastCBLLCeriBell2.8905 of 5 stars$14.96-1.1%$32.14+114.9%N/A$546.84M$65.44M0.00N/ANews CoverageEarnings ReportAnalyst RevisionBVSBioventus1.0628 of 5 stars$6.53-0.6%N/AN/A$539.69M$573.28M-13.601,200Earnings ReportSMLRSemler Scientific3.2885 of 5 stars$39.25+3.1%$82.00+108.9%+43.1%$525.05M$49.23M-15.04120Earnings ReportAnalyst ForecastZIMVZimVie0.894 of 5 stars$18.82+0.5%$17.00-9.7%+10.6%$521.30M$449.75M-26.511,770BFLYButterfly Network2.3836 of 5 stars$1.93-2.0%$3.50+81.3%+50.0%$487.16M$82.06M-6.66460Earnings ReportDCTHDelcath Systems3.0558 of 5 stars$11.41flat$24.00+110.3%+30.8%$397.37M$37.21M-22.8260News CoverageEarnings ReportAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies BBNX Competitors AXGN Competitors AVNS Competitors KIDS Competitors CBLL Competitors BVS Competitors SMLR Competitors ZIMV Competitors BFLY Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
